Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8⁺ T cells

Mike B. Barnkob^*, Yale S. Michaels, Violaine André, Philip S. Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna Kulicke, Ji Li Chen, Vitul Jain, Victoria K. Woodcock, Huw Colin-York, Andreas V. Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M. Mazet, Gracie Jennah Mead, Joshua A. Bull, Pramila Rijal, Christopher W. PughAlain R. Townsend, Audrey Gérard, Lars R. Olsen, Marco Fritzsche, Tudor A. Fulga, Michael L. Dustin, E. Yvonne Jones^*, Vincenzo Cerundolo

^*Corresponding author for this work

Department of Health Technology
Bioinformatics
Single Cell Omics

University of Oxford
University of Manitoba
University of Lisbon
Oregon Health and Science University
University of Cambridge

Research output: Contribution to journal › Journal article › Research › peer-review

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8⁺ T cells

Fingerprint

Medicine and Dentistry

Keyphrases

Immunology and Microbiology

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

Fingerprint

Medicine and Dentistry

Keyphrases

Immunology and Microbiology

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8⁺ T cells